CannaPharmaRX (CPMD) Stock Chart & Stock Price History $0.0030 0.00 (0.00%) (As of 11/21/2024 ET) Add Compare Share Share Chart Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest CannaPharmaRX Stock Price Performance 5 Day Performance-70.00%1 Month Performance-69.39%3 Month Performance-68.42%6 Month Performance-70.00%Year-To-Date Performance+76.47%1 Year Performance-40.00% Receive CPMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CannaPharmaRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Victory Just Kicked the Door Open to a… (Ad)This story is about a division that has been splitting America apart at the seams for the past three and a half years… Make no mistake, this division will definitely change YOUR financial future, for better or worse… That is why I’m sharing my post-election analysis of how this hidden division will impact your financial future…And how Trump’s victory has just kicked-opened the door to a “Financial Miracle” for every American. CPMD Stock Chart for Friday, November, 22, 2024 CPMD Chart by TradingView CannaPharmaRX Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/21/2024$0.01$0.00-45.45%$0.01$0.001.08 million shs$1.98 million11/20/2024$0.01$0.01-41.49%$0.01$0.011,000 shs$3.63 million11/18/2024$0.01$0.01-6.00%$0.01$0.01700 shs$6.21 million11/15/2024$0.01$0.01+17.65%$0.01$0.01815,830 shs$6.61 million11/14/2024$0.01$0.01$0.01$0.01198,188 shs$5.62 million11/13/2024$0.01$0.01-15.00%$0.01$0.01289,774 shs$5.62 million Get the Latest News and Ratings for CPMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CannaPharmaRX and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024$0.01$0.01+6.38%$0.01$0.01155,000 shs$6.61 million11/11/2024$0.01$0.01$0.01$0.0120,500 shs$6.21 million11/08/2024$0.01$0.01+4.44%$0.01$0.0110,250 shs$6.21 million11/07/2024$0.01$0.01-10.00%$0.01$0.015,000 shs$5.95 million11/06/2024$0.01$0.01$0.01$0.0184,900 shs$6.61 million11/05/2024$0.01$0.01$0.01$0.01100,200 shs$6.61 million11/04/2024$0.01$0.01-9.09%$0.01$0.01102,000 shs$6.61 million11/01/2024$0.01$0.01+22.22%$0.01$0.011.63 million shs$7.27 million10/31/2024$0.01$0.01-10.00%$0.01$0.01167,174 shs$5.95 million10/30/2024$0.01$0.01-9.09%$0.01$0.01304,550 shs$6.61 million10/29/2024$0.01$0.01+57.14%$0.01$0.01510,861 shs$7.27 million10/28/2024$0.01$0.01-28.57%$0.01$0.01156,015 shs$4.62 million10/25/2024$0.01$0.01$0.01$0.01151,297 shs$7.27 million10/24/2024$0.01$0.01+12.24%$0.01$0.0151,297 shs$7.27 million10/23/2024$0.01$0.01-10.91%$0.01$0.01110,450 shs$6.47 million10/22/2024$0.01$0.01+12.24%$0.01$0.01156,410 shs$7.27 million10/21/2024$0.01$0.01$0.01$0.01113,225 shs$6.47 million Related Companies Alterity Therapeutics Stock Chart Coeptis Therapeutics Stock Chart Galecto Stock Chart Biora Therapeutics Stock Chart Syros Pharmaceuticals Stock Chart ABVC BioPharma Stock Chart Brainstorm Cell Therapeutics Stock Chart Can-Fite BioPharma Stock Chart Edesa Biotech Stock Chart Eyenovia Stock Chart Receive CPMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CannaPharmaRX and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:CPMD) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredCan Trump Make Housing Great Again?Trump won. But can he undo the damage the Democrats have inflicted on this nation? Under Biden, inflatio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CannaPharmaRX, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CannaPharmaRX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CPMD Stock Alerts